Search results
Author(s):
Gerhard Hindricks
,
Faizel Osman
,
Keitaro Senoo
,
et al
Added:
4 months ago
This video series page covers content associated with Atrial Fibrillation.AFib is associated with a 5x greater risk of stroke, however with effective treatment, the risk of stroke can be reduced.¹ The lifetime risk for AFib is 1 in 3 individuals² and it often occurs with hypertension. Early detection is key, to allow for prompt and satisfactory disease management to not only control symptoms but…
View more
Author(s):
Konstantinos N Aronis
,
Brittany Edgar
,
Wendy Lin
,
et al
Added:
3 years ago
Atrial fibrillation (AF) requires complex management to prevent adverse outcomes. To succeed with AF, patients need to learn specialised medical terminology and the self-care skills and activation to interpret and report symptoms. AF care involves long-term adherence to medications with deleterious side-effects, such as antiarrhythmics and anticoagulants. The patient experience of AF is further…
View more
Author(s):
Gheorghe-Andrei Dan
,
Adrian Catalin Buzea
Added:
3 years ago
Non-antivitamin K oral anticoagulants (NOACs) are no longer ‘new’ drugs: they already are established. Since randomised controlled trials (RCTs) usually enrol highly selected patient populations, the best way to demonstrate new drug efficiency/cost-effectiveness is to use long-term and ‘real-world’ data. In order to understand the NOAC experience in real life properly, one must first understand…
View more
Author(s):
Akira Matsumori
Added:
1 year ago
Author(s):
Miriam Shteinshnaider
,
Dorit Almoznino-Sarafian
,
Sylvia Berman
,
et al
Added:
3 years ago
Abstract
Little is known about gender-related differences in clinical variables affecting the survival in inpatients with atrial fibrillation (AF). We recorded and compared clinical data and long-term mortality between 126 males and 124 females hospitalised with paroxysmal/persistent AF. Women were older and more symptomatic than men. Hypertension and renal dysfunction were more common in…
View more
The Place of Antiarrhythmic Drugs and Rhythm Control in the Treatment of Atrial Fibrillation
Author(s):
Philippe Chevalier
Added:
3 years ago
Article
Author(s):
Jonathan Piccini
Added:
1 year ago
AHA 22 - Dr Jonathan Piccini(Duke University Medical Center, Durham, US) joins us to discuss the findings of the NOVA Phase II trial (NCT03779841).
NOVA Phase II is a multicenter, randomized, dose-ranging study that aims to find the efficacy and safety of botulinum toxin type A (AGN-151607) (AbbVie)in preventing post-operative atrial fibrillation (POAF) in patients undergoing open-chest cardiac…
View more
Author(s):
Atul Verma
Added:
1 year ago
ACC.23/WCC - Principal Investigator, DrAtul Verma (McGill University Health Centre, CA) joins us on-site at ACC's 2023 Scientific Sessions to outline the findings of the PULSED-AF Trial(Medtronic Cardiac Rhythm and Heart Failure) (NCT04198701).
In this prospective, multicenter study, 421 patients with persistent atrial fibrillation (AF) were treated with the Medtronic PulseSelect Pulsed Field…
View more
Author(s):
Katrina Mountfort
,
Karl-Heinz Kuck
,
Richard Schilling
Added:
3 years ago
Atrial fibrillation (AF) is the most common arrhythmia and is associated with increased risk of stroke, heart failure and mortality.1 Following increased therapeutic options for AF, an update in guidelines for management of AF has been published. A symposium, chaired by Karl- Heinz Kuck, Hamburg, Germany, was held at the European Society of Cardiology (ESC) congress in Paris on the 2nd September…
View more
Author(s):
Antoni Martínez-Rubio
,
Mario DiazNuila-Alcazar
,
Anna Soria Cadena
,
et al
Added:
3 years ago
Atrial fibrillation (AF) is the most commonly encountered arrhythmia in clinical practice in Western countries. The prevalence of AF depends on the population studied1 and especially on age.2–9 It is affected by increasing longevity and is modulated by the prevalence of cardiovascular risk factors, especially arterial hypertension and related habits. In Spain, for example, the prevalence of AF…
View more